Clinical Trial Protocol: Randomized Placebo-Controlled Pilot Study of GcMAF (Soloways TM) in Patients With Metastatic Breast Cancer
NCT06434077
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
BIOLOGICAL:
GcMAF injections (100 ng)
OTHER:
placebo
Sponsor
S.LAB (SOLOWAYS)
Collaborators
[object Object]